ArticleBrain communications2025
The bi-phasic behaviour of grey matter networks after the first demyelinating attack.
Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis can be considered a network disease. Accumulating evidence recognizes the following importance of grey matter networks: they only require high-resolution anatomical scans for their extraction, they capture changes beyond detectable atrophy and their alteration is associated with disability progression and cognitive impairment. Therefore, it is crucial to understand their behaviours over the initial years of the disease. This observational longitudinal study aimed to investigate changes in grey matter networks after the first demyelinating attack, and how they correlate with brain damage, disability, and conversion to multiple sclerosis over 3-5 years. So far, in multiple sclerosis, network construction has only been based on cortical grey matter, neglecting a possible role for deep grey matter. We applied a radiomics-based network methodology incorporating both deep and cortical grey matter. Patients recruited within 3 months of disease onset and healthy controls attended study visits at 6 months, 1 year, 3 years and 5 years. Study visits included physical and cognitive scales and brain MRI scans. Individual grey matter networks were constructed by computing the correlations between T1w-based radiomic features extracted from any pair of regions of the Brainnetome atlas and characterized with measures of network integration (global efficiency and characteristic path length), segregation (clustering coefficient and modularity), resilience (assortativity) and smallworldness. Additionally, eigenvector centrality was computed for all brain regions as a measure of nodal influence. We enrolled 89 patients (median follow-up 7 months, range 0-75) and 31 healthy controls. Patients showed higher global efficiency, lower shortest characteristic path length and higher smallworldness than controls suggesting a reorganization that prioritize more efficient global communication over local processing. Over time, patients' networks converged towards healthy controls' values by increasing the shortest characteristic path length and decreasing the smallworldness. Assortativity, and the eigenvector centrality in the right ventromedial putamen decreased compared with controls. All the observed changes were driven by non-converters to multiple sclerosis. This study shows that grey matter networks adopt a biphasic behaviour. They respond to the demyelinating event with an increase in nodal integration and then converge to healthy control values. In the process, however, their network resilience is compromised. This suggests that a single demyelinating event has longer-lasting effects on grey matter networks, even in non-converters, and that studying these networks may reveal relevant changes that are not captured by conventional MRI in the early years of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.